Global Opioid Analgesics Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Opioid Analgesics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Opioid Analgesics players cover Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG and Bayer AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Opioid Analgesics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Opioid Analgesics market, with both quantitative and qualitative data, to help readers understand how the Opioid Analgesics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Tons.
Market Segmentation:
The study segments the Opioid Analgesics market and forecasts the market size by Type (OxyContin, Vicodin and Morphine), by Application (Surgical Pain, Cancer Pain, Neuropathic Pain and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Opioid Analgesics, Research Methodology, etc.
Chapter 2: Executive Summary, global Opioid Analgesics market size (sales and revenue) and CAGR, Opioid Analgesics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Opioid Analgesics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Opioid Analgesics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Opioid Analgesics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH and Bausch Health, etc.
Chapter 14: Research Findings and Conclusion
The global market for Opioid Analgesics is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Opioid Analgesics market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Opioid Analgesics players cover Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG and Bayer AG, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Opioid Analgesics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Opioid Analgesics market, with both quantitative and qualitative data, to help readers understand how the Opioid Analgesics market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Tons.
Market Segmentation:
The study segments the Opioid Analgesics market and forecasts the market size by Type (OxyContin, Vicodin and Morphine), by Application (Surgical Pain, Cancer Pain, Neuropathic Pain and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- OxyContin
- Vicodin
- Morphine
- Methadone
- Others
- Surgical Pain
- Cancer Pain
- Neuropathic Pain
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer Inc.
- Abbott Laboratories
- Johnson & Johnson
- Novartis AG
- Bayer AG
- GlaxoSmithKline plc
- F. Hoffmann-La Roche AG
- Boehringer Ingelheim International GmbH
- Bausch Health
- Sanofi S.A.
- Teva Pharmaceuticals
- Purdue Pharmaceuticals L.P.
- Endo International Plc
- Assertio Holdings, Inc
Chapter 1: Scope of Opioid Analgesics, Research Methodology, etc.
Chapter 2: Executive Summary, global Opioid Analgesics market size (sales and revenue) and CAGR, Opioid Analgesics market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Opioid Analgesics sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Opioid Analgesics sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Opioid Analgesics market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH and Bausch Health, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Analgesics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Opioid Analgesics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Opioid Analgesics by Country/Region, 2017, 2022 & 2028
2.2 Opioid Analgesics Segment by Type
2.2.1 OxyContin
2.2.2 Vicodin
2.2.3 Morphine
2.2.4 Methadone
2.2.5 Others
2.3 Opioid Analgesics Sales by Type
2.3.1 Global Opioid Analgesics Sales Market Share by Type (2017-2022)
2.3.2 Global Opioid Analgesics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Opioid Analgesics Sale Price by Type (2017-2022)
2.4 Opioid Analgesics Segment by Application
2.4.1 Surgical Pain
2.4.2 Cancer Pain
2.4.3 Neuropathic Pain
2.4.4 Others
2.5 Opioid Analgesics Sales by Application
2.5.1 Global Opioid Analgesics Sale Market Share by Application (2017-2022)
2.5.2 Global Opioid Analgesics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Opioid Analgesics Sale Price by Application (2017-2022)
3 GLOBAL OPIOID ANALGESICS BY COMPANY
3.1 Global Opioid Analgesics Breakdown Data by Company
3.1.1 Global Opioid Analgesics Annual Sales by Company (2020-2022)
3.1.2 Global Opioid Analgesics Sales Market Share by Company (2020-2022)
3.2 Global Opioid Analgesics Annual Revenue by Company (2020-2022)
3.2.1 Global Opioid Analgesics Revenue by Company (2020-2022)
3.2.2 Global Opioid Analgesics Revenue Market Share by Company (2020-2022)
3.3 Global Opioid Analgesics Sale Price by Company
3.4 Key Manufacturers Opioid Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Analgesics Product Location Distribution
3.4.2 Players Opioid Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID ANALGESICS BY GEOGRAPHIC REGION
4.1 World Historic Opioid Analgesics Market Size by Geographic Region (2017-2022)
4.1.1 Global Opioid Analgesics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Opioid Analgesics Annual Revenue by Geographic Region
4.2 World Historic Opioid Analgesics Market Size by Country/Region (2017-2022)
4.2.1 Global Opioid Analgesics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Opioid Analgesics Annual Revenue by Country/Region
4.3 Americas Opioid Analgesics Sales Growth
4.4 APAC Opioid Analgesics Sales Growth
4.5 Europe Opioid Analgesics Sales Growth
4.6 Middle East & Africa Opioid Analgesics Sales Growth
5 AMERICAS
5.1 Americas Opioid Analgesics Sales by Country
5.1.1 Americas Opioid Analgesics Sales by Country (2017-2022)
5.1.2 Americas Opioid Analgesics Revenue by Country (2017-2022)
5.2 Americas Opioid Analgesics Sales by Type
5.3 Americas Opioid Analgesics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Analgesics Sales by Region
6.1.1 APAC Opioid Analgesics Sales by Region (2017-2022)
6.1.2 APAC Opioid Analgesics Revenue by Region (2017-2022)
6.2 APAC Opioid Analgesics Sales by Type
6.3 APAC Opioid Analgesics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Analgesics by Country
7.1.1 Europe Opioid Analgesics Sales by Country (2017-2022)
7.1.2 Europe Opioid Analgesics Revenue by Country (2017-2022)
7.2 Europe Opioid Analgesics Sales by Type
7.3 Europe Opioid Analgesics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Analgesics by Country
8.1.1 Middle East & Africa Opioid Analgesics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Opioid Analgesics Revenue by Country (2017-2022)
8.2 Middle East & Africa Opioid Analgesics Sales by Type
8.3 Middle East & Africa Opioid Analgesics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Analgesics
10.3 Manufacturing Process Analysis of Opioid Analgesics
10.4 Industry Chain Structure of Opioid Analgesics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Analgesics Distributors
11.3 Opioid Analgesics Customer
12 WORLD FORECAST REVIEW FOR OPIOID ANALGESICS BY GEOGRAPHIC REGION
12.1 Global Opioid Analgesics Market Size Forecast by Region
12.1.1 Global Opioid Analgesics Forecast by Region (2023-2028)
12.1.2 Global Opioid Analgesics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Analgesics Forecast by Type
12.7 Global Opioid Analgesics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Opioid Analgesics Product Offered
13.1.3 Pfizer Inc. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Opioid Analgesics Product Offered
13.2.3 Abbott Laboratories Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Opioid Analgesics Product Offered
13.3.3 Johnson & Johnson Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Novartis AG
13.4.1 Novartis AG Company Information
13.4.2 Novartis AG Opioid Analgesics Product Offered
13.4.3 Novartis AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis AG Main Business Overview
13.4.5 Novartis AG Latest Developments
13.5 Bayer AG
13.5.1 Bayer AG Company Information
13.5.2 Bayer AG Opioid Analgesics Product Offered
13.5.3 Bayer AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer AG Main Business Overview
13.5.5 Bayer AG Latest Developments
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Information
13.6.2 GlaxoSmithKline plc Opioid Analgesics Product Offered
13.6.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GlaxoSmithKline plc Main Business Overview
13.6.5 GlaxoSmithKline plc Latest Developments
13.7 F. Hoffmann-La Roche AG
13.7.1 F. Hoffmann-La Roche AG Company Information
13.7.2 F. Hoffmann-La Roche AG Opioid Analgesics Product Offered
13.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 F. Hoffmann-La Roche AG Main Business Overview
13.7.5 F. Hoffmann-La Roche AG Latest Developments
13.8 Boehringer Ingelheim International GmbH
13.8.1 Boehringer Ingelheim International GmbH Company Information
13.8.2 Boehringer Ingelheim International GmbH Opioid Analgesics Product Offered
13.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Boehringer Ingelheim International GmbH Main Business Overview
13.8.5 Boehringer Ingelheim International GmbH Latest Developments
13.9 Bausch Health
13.9.1 Bausch Health Company Information
13.9.2 Bausch Health Opioid Analgesics Product Offered
13.9.3 Bausch Health Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bausch Health Main Business Overview
13.9.5 Bausch Health Latest Developments
13.10 Sanofi S.A.
13.10.1 Sanofi S.A. Company Information
13.10.2 Sanofi S.A. Opioid Analgesics Product Offered
13.10.3 Sanofi S.A. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi S.A. Main Business Overview
13.10.5 Sanofi S.A. Latest Developments
13.11 Teva Pharmaceuticals
13.11.1 Teva Pharmaceuticals Company Information
13.11.2 Teva Pharmaceuticals Opioid Analgesics Product Offered
13.11.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Teva Pharmaceuticals Main Business Overview
13.11.5 Teva Pharmaceuticals Latest Developments
13.12 Purdue Pharmaceuticals L.P.
13.12.1 Purdue Pharmaceuticals L.P. Company Information
13.12.2 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Offered
13.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Purdue Pharmaceuticals L.P. Main Business Overview
13.12.5 Purdue Pharmaceuticals L.P. Latest Developments
13.13 Endo International Plc
13.13.1 Endo International Plc Company Information
13.13.2 Endo International Plc Opioid Analgesics Product Offered
13.13.3 Endo International Plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Endo International Plc Main Business Overview
13.13.5 Endo International Plc Latest Developments
13.14 Assertio Holdings, Inc
13.14.1 Assertio Holdings, Inc Company Information
13.14.2 Assertio Holdings, Inc Opioid Analgesics Product Offered
13.14.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Assertio Holdings, Inc Main Business Overview
13.14.5 Assertio Holdings, Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Opioid Analgesics Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Opioid Analgesics by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Opioid Analgesics by Country/Region, 2017, 2022 & 2028
2.2 Opioid Analgesics Segment by Type
2.2.1 OxyContin
2.2.2 Vicodin
2.2.3 Morphine
2.2.4 Methadone
2.2.5 Others
2.3 Opioid Analgesics Sales by Type
2.3.1 Global Opioid Analgesics Sales Market Share by Type (2017-2022)
2.3.2 Global Opioid Analgesics Revenue and Market Share by Type (2017-2022)
2.3.3 Global Opioid Analgesics Sale Price by Type (2017-2022)
2.4 Opioid Analgesics Segment by Application
2.4.1 Surgical Pain
2.4.2 Cancer Pain
2.4.3 Neuropathic Pain
2.4.4 Others
2.5 Opioid Analgesics Sales by Application
2.5.1 Global Opioid Analgesics Sale Market Share by Application (2017-2022)
2.5.2 Global Opioid Analgesics Revenue and Market Share by Application (2017-2022)
2.5.3 Global Opioid Analgesics Sale Price by Application (2017-2022)
3 GLOBAL OPIOID ANALGESICS BY COMPANY
3.1 Global Opioid Analgesics Breakdown Data by Company
3.1.1 Global Opioid Analgesics Annual Sales by Company (2020-2022)
3.1.2 Global Opioid Analgesics Sales Market Share by Company (2020-2022)
3.2 Global Opioid Analgesics Annual Revenue by Company (2020-2022)
3.2.1 Global Opioid Analgesics Revenue by Company (2020-2022)
3.2.2 Global Opioid Analgesics Revenue Market Share by Company (2020-2022)
3.3 Global Opioid Analgesics Sale Price by Company
3.4 Key Manufacturers Opioid Analgesics Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid Analgesics Product Location Distribution
3.4.2 Players Opioid Analgesics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR OPIOID ANALGESICS BY GEOGRAPHIC REGION
4.1 World Historic Opioid Analgesics Market Size by Geographic Region (2017-2022)
4.1.1 Global Opioid Analgesics Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Opioid Analgesics Annual Revenue by Geographic Region
4.2 World Historic Opioid Analgesics Market Size by Country/Region (2017-2022)
4.2.1 Global Opioid Analgesics Annual Sales by Country/Region (2017-2022)
4.2.2 Global Opioid Analgesics Annual Revenue by Country/Region
4.3 Americas Opioid Analgesics Sales Growth
4.4 APAC Opioid Analgesics Sales Growth
4.5 Europe Opioid Analgesics Sales Growth
4.6 Middle East & Africa Opioid Analgesics Sales Growth
5 AMERICAS
5.1 Americas Opioid Analgesics Sales by Country
5.1.1 Americas Opioid Analgesics Sales by Country (2017-2022)
5.1.2 Americas Opioid Analgesics Revenue by Country (2017-2022)
5.2 Americas Opioid Analgesics Sales by Type
5.3 Americas Opioid Analgesics Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid Analgesics Sales by Region
6.1.1 APAC Opioid Analgesics Sales by Region (2017-2022)
6.1.2 APAC Opioid Analgesics Revenue by Region (2017-2022)
6.2 APAC Opioid Analgesics Sales by Type
6.3 APAC Opioid Analgesics Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Opioid Analgesics by Country
7.1.1 Europe Opioid Analgesics Sales by Country (2017-2022)
7.1.2 Europe Opioid Analgesics Revenue by Country (2017-2022)
7.2 Europe Opioid Analgesics Sales by Type
7.3 Europe Opioid Analgesics Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Opioid Analgesics by Country
8.1.1 Middle East & Africa Opioid Analgesics Sales by Country (2017-2022)
8.1.2 Middle East & Africa Opioid Analgesics Revenue by Country (2017-2022)
8.2 Middle East & Africa Opioid Analgesics Sales by Type
8.3 Middle East & Africa Opioid Analgesics Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Opioid Analgesics
10.3 Manufacturing Process Analysis of Opioid Analgesics
10.4 Industry Chain Structure of Opioid Analgesics
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Opioid Analgesics Distributors
11.3 Opioid Analgesics Customer
12 WORLD FORECAST REVIEW FOR OPIOID ANALGESICS BY GEOGRAPHIC REGION
12.1 Global Opioid Analgesics Market Size Forecast by Region
12.1.1 Global Opioid Analgesics Forecast by Region (2023-2028)
12.1.2 Global Opioid Analgesics Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Opioid Analgesics Forecast by Type
12.7 Global Opioid Analgesics Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer Inc.
13.1.1 Pfizer Inc. Company Information
13.1.2 Pfizer Inc. Opioid Analgesics Product Offered
13.1.3 Pfizer Inc. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Inc. Main Business Overview
13.1.5 Pfizer Inc. Latest Developments
13.2 Abbott Laboratories
13.2.1 Abbott Laboratories Company Information
13.2.2 Abbott Laboratories Opioid Analgesics Product Offered
13.2.3 Abbott Laboratories Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Abbott Laboratories Main Business Overview
13.2.5 Abbott Laboratories Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Opioid Analgesics Product Offered
13.3.3 Johnson & Johnson Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Novartis AG
13.4.1 Novartis AG Company Information
13.4.2 Novartis AG Opioid Analgesics Product Offered
13.4.3 Novartis AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Novartis AG Main Business Overview
13.4.5 Novartis AG Latest Developments
13.5 Bayer AG
13.5.1 Bayer AG Company Information
13.5.2 Bayer AG Opioid Analgesics Product Offered
13.5.3 Bayer AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bayer AG Main Business Overview
13.5.5 Bayer AG Latest Developments
13.6 GlaxoSmithKline plc
13.6.1 GlaxoSmithKline plc Company Information
13.6.2 GlaxoSmithKline plc Opioid Analgesics Product Offered
13.6.3 GlaxoSmithKline plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GlaxoSmithKline plc Main Business Overview
13.6.5 GlaxoSmithKline plc Latest Developments
13.7 F. Hoffmann-La Roche AG
13.7.1 F. Hoffmann-La Roche AG Company Information
13.7.2 F. Hoffmann-La Roche AG Opioid Analgesics Product Offered
13.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 F. Hoffmann-La Roche AG Main Business Overview
13.7.5 F. Hoffmann-La Roche AG Latest Developments
13.8 Boehringer Ingelheim International GmbH
13.8.1 Boehringer Ingelheim International GmbH Company Information
13.8.2 Boehringer Ingelheim International GmbH Opioid Analgesics Product Offered
13.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Boehringer Ingelheim International GmbH Main Business Overview
13.8.5 Boehringer Ingelheim International GmbH Latest Developments
13.9 Bausch Health
13.9.1 Bausch Health Company Information
13.9.2 Bausch Health Opioid Analgesics Product Offered
13.9.3 Bausch Health Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Bausch Health Main Business Overview
13.9.5 Bausch Health Latest Developments
13.10 Sanofi S.A.
13.10.1 Sanofi S.A. Company Information
13.10.2 Sanofi S.A. Opioid Analgesics Product Offered
13.10.3 Sanofi S.A. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sanofi S.A. Main Business Overview
13.10.5 Sanofi S.A. Latest Developments
13.11 Teva Pharmaceuticals
13.11.1 Teva Pharmaceuticals Company Information
13.11.2 Teva Pharmaceuticals Opioid Analgesics Product Offered
13.11.3 Teva Pharmaceuticals Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Teva Pharmaceuticals Main Business Overview
13.11.5 Teva Pharmaceuticals Latest Developments
13.12 Purdue Pharmaceuticals L.P.
13.12.1 Purdue Pharmaceuticals L.P. Company Information
13.12.2 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Offered
13.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Purdue Pharmaceuticals L.P. Main Business Overview
13.12.5 Purdue Pharmaceuticals L.P. Latest Developments
13.13 Endo International Plc
13.13.1 Endo International Plc Company Information
13.13.2 Endo International Plc Opioid Analgesics Product Offered
13.13.3 Endo International Plc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Endo International Plc Main Business Overview
13.13.5 Endo International Plc Latest Developments
13.14 Assertio Holdings, Inc
13.14.1 Assertio Holdings, Inc Company Information
13.14.2 Assertio Holdings, Inc Opioid Analgesics Product Offered
13.14.3 Assertio Holdings, Inc Opioid Analgesics Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Assertio Holdings, Inc Main Business Overview
13.14.5 Assertio Holdings, Inc Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Opioid Analgesics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Opioid Analgesics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of OxyContin
Table 4. Major Players of Vicodin
Table 5. Major Players of Morphine
Table 6. Major Players of Methadone
Table 7. Major Players of Others
Table 8. Global Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 9. Global Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 10. Global Opioid Analgesics Revenue by Type (2017-2022) & ($ million)
Table 11. Global Opioid Analgesics Revenue Market Share by Type (2017-2022)
Table 12. Global Opioid Analgesics Sale Price by Type (2017-2022) & (US$/Ton)
Table 13. Global Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 14. Global Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 15. Global Opioid Analgesics Revenue by Application (2017-2022)
Table 16. Global Opioid Analgesics Revenue Market Share by Application (2017-2022)
Table 17. Global Opioid Analgesics Sale Price by Application (2017-2022) & (US$/Ton)
Table 18. Global Opioid Analgesics Sales by Company (2020-2022) & (K Tons)
Table 19. Global Opioid Analgesics Sales Market Share by Company (2020-2022)
Table 20. Global Opioid Analgesics Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Opioid Analgesics Revenue Market Share by Company (2020-2022)
Table 22. Global Opioid Analgesics Sale Price by Company (2020-2022) & (US$/Ton)
Table 23. Key Manufacturers Opioid Analgesics Producing Area Distribution and Sales Area
Table 24. Players Opioid Analgesics Products Offered
Table 25. Opioid Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioid Analgesics Sales by Geographic Region (2017-2022) & (K Tons)
Table 29. Global Opioid Analgesics Sales Market Share Geographic Region (2017-2022)
Table 30. Global Opioid Analgesics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Opioid Analgesics Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Opioid Analgesics Sales by Country/Region (2017-2022) & (K Tons)
Table 33. Global Opioid Analgesics Sales Market Share by Country/Region (2017-2022)
Table 34. Global Opioid Analgesics Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Opioid Analgesics Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 37. Americas Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 38. Americas Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 40. Americas Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 41. Americas Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 42. Americas Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 43. Americas Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 44. APAC Opioid Analgesics Sales by Region (2017-2022) & (K Tons)
Table 45. APAC Opioid Analgesics Sales Market Share by Region (2017-2022)
Table 46. APAC Opioid Analgesics Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Opioid Analgesics Revenue Market Share by Region (2017-2022)
Table 48. APAC Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 49. APAC Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 50. APAC Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 51. APAC Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 52. Europe Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 53. Europe Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 54. Europe Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 56. Europe Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 57. Europe Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 58. Europe Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 59. Europe Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 61. Middle East & Africa Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 65. Middle East & Africa Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 67. Middle East & Africa Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Opioid Analgesics
Table 69. Key Market Challenges & Risks of Opioid Analgesics
Table 70. Key Industry Trends of Opioid Analgesics
Table 71. Opioid Analgesics Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Opioid Analgesics Distributors List
Table 74. Opioid Analgesics Customer List
Table 75. Global Opioid Analgesics Sales Forecast by Region (2023-2028) & (K Tons)
Table 76. Global Opioid Analgesics Sales Market Forecast by Region
Table 77. Global Opioid Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Opioid Analgesics Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 80. Americas Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Opioid Analgesics Sales Forecast by Region (2023-2028) & (K Tons)
Table 82. APAC Opioid Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 84. Europe Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 86. Middle East & Africa Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Opioid Analgesics Sales Forecast by Type (2023-2028) & (K Tons)
Table 88. Global Opioid Analgesics Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Opioid Analgesics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Opioid Analgesics Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Opioid Analgesics Sales Forecast by Application (2023-2028) & (K Tons)
Table 92. Global Opioid Analgesics Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Opioid Analgesics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Opioid Analgesics Revenue Market Share Forecast by Application (2023-2028)
Table 95. Pfizer Inc. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Inc. Opioid Analgesics Product Offered
Table 97. Pfizer Inc. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 98. Pfizer Inc. Main Business
Table 99. Pfizer Inc. Latest Developments
Table 100. Abbott Laboratories Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 101. Abbott Laboratories Opioid Analgesics Product Offered
Table 102. Abbott Laboratories Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 103. Abbott Laboratories Main Business
Table 104. Abbott Laboratories Latest Developments
Table 105. Johnson & Johnson Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Opioid Analgesics Product Offered
Table 107. Johnson & Johnson Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Novartis AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 111. Novartis AG Opioid Analgesics Product Offered
Table 112. Novartis AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Bayer AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer AG Opioid Analgesics Product Offered
Table 117. Bayer AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 118. Bayer AG Main Business
Table 119. Bayer AG Latest Developments
Table 120. GlaxoSmithKline plc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 121. GlaxoSmithKline plc Opioid Analgesics Product Offered
Table 122. GlaxoSmithKline plc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 123. GlaxoSmithKline plc Main Business
Table 124. GlaxoSmithKline plc Latest Developments
Table 125. F. Hoffmann-La Roche AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 126. F. Hoffmann-La Roche AG Opioid Analgesics Product Offered
Table 127. F. Hoffmann-La Roche AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 128. F. Hoffmann-La Roche AG Main Business
Table 129. F. Hoffmann-La Roche AG Latest Developments
Table 130. Boehringer Ingelheim International GmbH Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 131. Boehringer Ingelheim International GmbH Opioid Analgesics Product Offered
Table 132. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 133. Boehringer Ingelheim International GmbH Main Business
Table 134. Boehringer Ingelheim International GmbH Latest Developments
Table 135. Bausch Health Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 136. Bausch Health Opioid Analgesics Product Offered
Table 137. Bausch Health Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 138. Bausch Health Main Business
Table 139. Bausch Health Latest Developments
Table 140. Sanofi S.A. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 141. Sanofi S.A. Opioid Analgesics Product Offered
Table 142. Sanofi S.A. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 143. Sanofi S.A. Main Business
Table 144. Sanofi S.A. Latest Developments
Table 145. Teva Pharmaceuticals Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 146. Teva Pharmaceuticals Opioid Analgesics Product Offered
Table 147. Teva Pharmaceuticals Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 148. Teva Pharmaceuticals Main Business
Table 149. Teva Pharmaceuticals Latest Developments
Table 150. Purdue Pharmaceuticals L.P. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Offered
Table 152. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 153. Purdue Pharmaceuticals L.P. Main Business
Table 154. Purdue Pharmaceuticals L.P. Latest Developments
Table 155. Endo International Plc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 156. Endo International Plc Opioid Analgesics Product Offered
Table 157. Endo International Plc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 158. Endo International Plc Main Business
Table 159. Endo International Plc Latest Developments
Table 160. Assertio Holdings, Inc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 161. Assertio Holdings, Inc Opioid Analgesics Product Offered
Table 162. Assertio Holdings, Inc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 163. Assertio Holdings, Inc Main Business
Table 164. Assertio Holdings, Inc Latest Developments
Table 1. Opioid Analgesics Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Opioid Analgesics Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of OxyContin
Table 4. Major Players of Vicodin
Table 5. Major Players of Morphine
Table 6. Major Players of Methadone
Table 7. Major Players of Others
Table 8. Global Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 9. Global Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 10. Global Opioid Analgesics Revenue by Type (2017-2022) & ($ million)
Table 11. Global Opioid Analgesics Revenue Market Share by Type (2017-2022)
Table 12. Global Opioid Analgesics Sale Price by Type (2017-2022) & (US$/Ton)
Table 13. Global Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 14. Global Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 15. Global Opioid Analgesics Revenue by Application (2017-2022)
Table 16. Global Opioid Analgesics Revenue Market Share by Application (2017-2022)
Table 17. Global Opioid Analgesics Sale Price by Application (2017-2022) & (US$/Ton)
Table 18. Global Opioid Analgesics Sales by Company (2020-2022) & (K Tons)
Table 19. Global Opioid Analgesics Sales Market Share by Company (2020-2022)
Table 20. Global Opioid Analgesics Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Opioid Analgesics Revenue Market Share by Company (2020-2022)
Table 22. Global Opioid Analgesics Sale Price by Company (2020-2022) & (US$/Ton)
Table 23. Key Manufacturers Opioid Analgesics Producing Area Distribution and Sales Area
Table 24. Players Opioid Analgesics Products Offered
Table 25. Opioid Analgesics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Opioid Analgesics Sales by Geographic Region (2017-2022) & (K Tons)
Table 29. Global Opioid Analgesics Sales Market Share Geographic Region (2017-2022)
Table 30. Global Opioid Analgesics Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Opioid Analgesics Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Opioid Analgesics Sales by Country/Region (2017-2022) & (K Tons)
Table 33. Global Opioid Analgesics Sales Market Share by Country/Region (2017-2022)
Table 34. Global Opioid Analgesics Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Opioid Analgesics Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 37. Americas Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 38. Americas Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 40. Americas Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 41. Americas Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 42. Americas Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 43. Americas Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 44. APAC Opioid Analgesics Sales by Region (2017-2022) & (K Tons)
Table 45. APAC Opioid Analgesics Sales Market Share by Region (2017-2022)
Table 46. APAC Opioid Analgesics Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Opioid Analgesics Revenue Market Share by Region (2017-2022)
Table 48. APAC Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 49. APAC Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 50. APAC Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 51. APAC Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 52. Europe Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 53. Europe Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 54. Europe Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 56. Europe Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 57. Europe Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 58. Europe Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 59. Europe Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Opioid Analgesics Sales by Country (2017-2022) & (K Tons)
Table 61. Middle East & Africa Opioid Analgesics Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Opioid Analgesics Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Opioid Analgesics Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Opioid Analgesics Sales by Type (2017-2022) & (K Tons)
Table 65. Middle East & Africa Opioid Analgesics Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Opioid Analgesics Sales by Application (2017-2022) & (K Tons)
Table 67. Middle East & Africa Opioid Analgesics Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Opioid Analgesics
Table 69. Key Market Challenges & Risks of Opioid Analgesics
Table 70. Key Industry Trends of Opioid Analgesics
Table 71. Opioid Analgesics Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Opioid Analgesics Distributors List
Table 74. Opioid Analgesics Customer List
Table 75. Global Opioid Analgesics Sales Forecast by Region (2023-2028) & (K Tons)
Table 76. Global Opioid Analgesics Sales Market Forecast by Region
Table 77. Global Opioid Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Opioid Analgesics Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 80. Americas Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Opioid Analgesics Sales Forecast by Region (2023-2028) & (K Tons)
Table 82. APAC Opioid Analgesics Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 84. Europe Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Opioid Analgesics Sales Forecast by Country (2023-2028) & (K Tons)
Table 86. Middle East & Africa Opioid Analgesics Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Opioid Analgesics Sales Forecast by Type (2023-2028) & (K Tons)
Table 88. Global Opioid Analgesics Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Opioid Analgesics Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Opioid Analgesics Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Opioid Analgesics Sales Forecast by Application (2023-2028) & (K Tons)
Table 92. Global Opioid Analgesics Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Opioid Analgesics Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Opioid Analgesics Revenue Market Share Forecast by Application (2023-2028)
Table 95. Pfizer Inc. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Inc. Opioid Analgesics Product Offered
Table 97. Pfizer Inc. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 98. Pfizer Inc. Main Business
Table 99. Pfizer Inc. Latest Developments
Table 100. Abbott Laboratories Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 101. Abbott Laboratories Opioid Analgesics Product Offered
Table 102. Abbott Laboratories Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 103. Abbott Laboratories Main Business
Table 104. Abbott Laboratories Latest Developments
Table 105. Johnson & Johnson Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 106. Johnson & Johnson Opioid Analgesics Product Offered
Table 107. Johnson & Johnson Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 108. Johnson & Johnson Main Business
Table 109. Johnson & Johnson Latest Developments
Table 110. Novartis AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 111. Novartis AG Opioid Analgesics Product Offered
Table 112. Novartis AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 113. Novartis AG Main Business
Table 114. Novartis AG Latest Developments
Table 115. Bayer AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 116. Bayer AG Opioid Analgesics Product Offered
Table 117. Bayer AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 118. Bayer AG Main Business
Table 119. Bayer AG Latest Developments
Table 120. GlaxoSmithKline plc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 121. GlaxoSmithKline plc Opioid Analgesics Product Offered
Table 122. GlaxoSmithKline plc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 123. GlaxoSmithKline plc Main Business
Table 124. GlaxoSmithKline plc Latest Developments
Table 125. F. Hoffmann-La Roche AG Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 126. F. Hoffmann-La Roche AG Opioid Analgesics Product Offered
Table 127. F. Hoffmann-La Roche AG Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 128. F. Hoffmann-La Roche AG Main Business
Table 129. F. Hoffmann-La Roche AG Latest Developments
Table 130. Boehringer Ingelheim International GmbH Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 131. Boehringer Ingelheim International GmbH Opioid Analgesics Product Offered
Table 132. Boehringer Ingelheim International GmbH Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 133. Boehringer Ingelheim International GmbH Main Business
Table 134. Boehringer Ingelheim International GmbH Latest Developments
Table 135. Bausch Health Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 136. Bausch Health Opioid Analgesics Product Offered
Table 137. Bausch Health Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 138. Bausch Health Main Business
Table 139. Bausch Health Latest Developments
Table 140. Sanofi S.A. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 141. Sanofi S.A. Opioid Analgesics Product Offered
Table 142. Sanofi S.A. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 143. Sanofi S.A. Main Business
Table 144. Sanofi S.A. Latest Developments
Table 145. Teva Pharmaceuticals Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 146. Teva Pharmaceuticals Opioid Analgesics Product Offered
Table 147. Teva Pharmaceuticals Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 148. Teva Pharmaceuticals Main Business
Table 149. Teva Pharmaceuticals Latest Developments
Table 150. Purdue Pharmaceuticals L.P. Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 151. Purdue Pharmaceuticals L.P. Opioid Analgesics Product Offered
Table 152. Purdue Pharmaceuticals L.P. Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 153. Purdue Pharmaceuticals L.P. Main Business
Table 154. Purdue Pharmaceuticals L.P. Latest Developments
Table 155. Endo International Plc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 156. Endo International Plc Opioid Analgesics Product Offered
Table 157. Endo International Plc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 158. Endo International Plc Main Business
Table 159. Endo International Plc Latest Developments
Table 160. Assertio Holdings, Inc Basic Information, Opioid Analgesics Manufacturing Base, Sales Area and Its Competitors
Table 161. Assertio Holdings, Inc Opioid Analgesics Product Offered
Table 162. Assertio Holdings, Inc Opioid Analgesics Sales (K Tons), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)
Table 163. Assertio Holdings, Inc Main Business
Table 164. Assertio Holdings, Inc Latest Developments
LIST OF FIGURES
Figure 1. Picture of Opioid Analgesics
Figure 2. Opioid Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Analgesics Sales Growth Rate 2017-2028 (K Tons)
Figure 7. Global Opioid Analgesics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Opioid Analgesics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of OxyContin
Figure 10. Product Picture of Vicodin
Figure 11. Product Picture of Morphine
Figure 12. Product Picture of Methadone
Figure 13. Product Picture of Others
Figure 14. Global Opioid Analgesics Sales Market Share by Type in 2021
Figure 15. Global Opioid Analgesics Revenue Market Share by Type (2017-2022)
Figure 16. Opioid Analgesics Consumed in Surgical Pain
Figure 17. Global Opioid Analgesics Market: Surgical Pain (2017-2022) & (K Tons)
Figure 18. Opioid Analgesics Consumed in Cancer Pain
Figure 19. Global Opioid Analgesics Market: Cancer Pain (2017-2022) & (K Tons)
Figure 20. Opioid Analgesics Consumed in Neuropathic Pain
Figure 21. Global Opioid Analgesics Market: Neuropathic Pain (2017-2022) & (K Tons)
Figure 22. Opioid Analgesics Consumed in Others
Figure 23. Global Opioid Analgesics Market: Others (2017-2022) & (K Tons)
Figure 24. Global Opioid Analgesics Sales Market Share by Application (2017-2022)
Figure 25. Global Opioid Analgesics Revenue Market Share by Application in 2021
Figure 26. Opioid Analgesics Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Opioid Analgesics Revenue Market Share by Company in 2021
Figure 28. Global Opioid Analgesics Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Opioid Analgesics Revenue Market Share by Geographic Region in 2021
Figure 30. Global Opioid Analgesics Sales Market Share by Region (2017-2022)
Figure 31. Global Opioid Analgesics Revenue Market Share by Country/Region in 2021
Figure 32. Americas Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 33. Americas Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 34. APAC Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 35. APAC Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 36. Europe Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 37. Europe Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 39. Middle East & Africa Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 40. Americas Opioid Analgesics Sales Market Share by Country in 2021
Figure 41. Americas Opioid Analgesics Revenue Market Share by Country in 2021
Figure 42. United States Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Opioid Analgesics Sales Market Share by Region in 2021
Figure 47. APAC Opioid Analgesics Revenue Market Share by Regions in 2021
Figure 48. China Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Opioid Analgesics Sales Market Share by Country in 2021
Figure 55. Europe Opioid Analgesics Revenue Market Share by Country in 2021
Figure 56. Germany Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Opioid Analgesics Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Opioid Analgesics Revenue Market Share by Country in 2021
Figure 63. Egypt Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Opioid Analgesics in 2021
Figure 69. Manufacturing Process Analysis of Opioid Analgesics
Figure 70. Industry Chain Structure of Opioid Analgesics
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Figure 1. Picture of Opioid Analgesics
Figure 2. Opioid Analgesics Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid Analgesics Sales Growth Rate 2017-2028 (K Tons)
Figure 7. Global Opioid Analgesics Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Opioid Analgesics Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of OxyContin
Figure 10. Product Picture of Vicodin
Figure 11. Product Picture of Morphine
Figure 12. Product Picture of Methadone
Figure 13. Product Picture of Others
Figure 14. Global Opioid Analgesics Sales Market Share by Type in 2021
Figure 15. Global Opioid Analgesics Revenue Market Share by Type (2017-2022)
Figure 16. Opioid Analgesics Consumed in Surgical Pain
Figure 17. Global Opioid Analgesics Market: Surgical Pain (2017-2022) & (K Tons)
Figure 18. Opioid Analgesics Consumed in Cancer Pain
Figure 19. Global Opioid Analgesics Market: Cancer Pain (2017-2022) & (K Tons)
Figure 20. Opioid Analgesics Consumed in Neuropathic Pain
Figure 21. Global Opioid Analgesics Market: Neuropathic Pain (2017-2022) & (K Tons)
Figure 22. Opioid Analgesics Consumed in Others
Figure 23. Global Opioid Analgesics Market: Others (2017-2022) & (K Tons)
Figure 24. Global Opioid Analgesics Sales Market Share by Application (2017-2022)
Figure 25. Global Opioid Analgesics Revenue Market Share by Application in 2021
Figure 26. Opioid Analgesics Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Opioid Analgesics Revenue Market Share by Company in 2021
Figure 28. Global Opioid Analgesics Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Opioid Analgesics Revenue Market Share by Geographic Region in 2021
Figure 30. Global Opioid Analgesics Sales Market Share by Region (2017-2022)
Figure 31. Global Opioid Analgesics Revenue Market Share by Country/Region in 2021
Figure 32. Americas Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 33. Americas Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 34. APAC Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 35. APAC Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 36. Europe Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 37. Europe Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Opioid Analgesics Sales 2017-2022 (K Tons)
Figure 39. Middle East & Africa Opioid Analgesics Revenue 2017-2022 ($ Millions)
Figure 40. Americas Opioid Analgesics Sales Market Share by Country in 2021
Figure 41. Americas Opioid Analgesics Revenue Market Share by Country in 2021
Figure 42. United States Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Opioid Analgesics Sales Market Share by Region in 2021
Figure 47. APAC Opioid Analgesics Revenue Market Share by Regions in 2021
Figure 48. China Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Opioid Analgesics Sales Market Share by Country in 2021
Figure 55. Europe Opioid Analgesics Revenue Market Share by Country in 2021
Figure 56. Germany Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Opioid Analgesics Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Opioid Analgesics Revenue Market Share by Country in 2021
Figure 63. Egypt Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Opioid Analgesics Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Opioid Analgesics in 2021
Figure 69. Manufacturing Process Analysis of Opioid Analgesics
Figure 70. Industry Chain Structure of Opioid Analgesics
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
